Molecular diagnostics specialist Genedrive PLC (LON:GDR) said it has made the first US shipments of its 96 SARS-CoV-2 Covid PCR kits following the completion of commercial and technical training with sales staff from partner Beckman Coulter.
Open Orphan PLC (LON:ORPH) shares rose on Wednesday as the company said the world’s first coronavirus (COVID-19) characterisation study has received approval from a specially convened Research Ethics Committee (REC) following a contract received by the company’s subsidiary hVIVO from the UK government to develop a COVID-19 human challenge study model.
Silence Therapeutics PLC (LON:SLN, NASDAQ:SLN) said it has begun dosing patients with SLN360, a putative treatment for elevated Lipoprotein (a), ‘bad’ cholesterol associated with increased risk of heart disease.
Albion Technology & General VCT PLC (LON:AATG) said it has elected to exercise £1.5mln of the £3mln over-allotment facility referred to in the Top Up offer prospectus. Accordingly, the maximum amount that the company can raise is increased from £14mln to £15.5mln (before issue costs).
Seneca Global Income & Growth Trust PLC (LON:SIGT) said it will maintain its dividend at the current level at least until April 2022. Following the takeover of its manager Seneca, the company’s name will be changing to Momentum Multi-Asset Value Trust PLC.
DeepVerge PLC (LON:DVRG) said it has signed contractual obligations for the production of water contamination equipment worth around (US$5mln) £3.6mln off the back of its acquisition of Modern Water in November.
Emmerson PLC (LON:EML) told investors it is now assessing a staged development for its Khemisset potash project, in Morocco, with a move that would reduce upfront costs whilst significantly expanding the envisaged life-of-mine production volumes.
Oracle Power PLC (LON:ORCP) notified that it has received a notice of exercise in respect of certain pre-existing warrants to subscribe for a total of 6mln new ordinary shares at a price of 0.25p per share. The exercise of these warrants amounts to an aggregate cash subscription of £15,000.
Advanced Oncotherapy (LON:AVO) announced that it has received a warrant exercise notice in respect of 500,000 new ordinary shares with an exercise price of 25p per share. Proceeds of £125,000 have been received.
Live Company Group PLC (LON:LVCG) said that non-executive director Simon Horgan will step down from the board with immediate effect for personal reasons. The board now consists of David Ciclitira, chair; Serenella Ciclitira, Bryan Lawrie and Ranjit Murugason as non-executive directors, with non-board directors including Sarah Dees as chief operating officer and Richard Collett as chief financial officer.
Argo Blockchain PLC (LON:ARB) told investors that it will today publish a notice of general meeting with related explanatory circular and form of proxy. The notice and circular contain resolutions to approve the issuance of new shares, which will be put to shareholders at a general meeting at 10am on 5 March 2021. Due to UK government restrictions, the meeting will be run as a closed meeting and shareholders will need to vote by proxy.
Litigation Capital Management Limited (LON:LIT) said it will announce its interim results for the six months to 31 December 2020 on Tuesday 16 March 2021. A webinar presentation for analysts will take place at 9am on the day. A recording of the event will subsequently be made available on the company’s website.